Sint Maartenskliniek Stichting
- Address
- lock Available on a paid plan
Musculoskeletal Diseases
At Sint Maartenskliniek Stichting in Ubbergen, much of the clinical research focuses on musculoskeletal diseases, especially osteoarthritis, hand osteoarthritis, and related joint conditions. These studies are designed to evaluate treatments that may reduce pain, improve function, and delay the need for joint replacement.
- Research on osteoarthritis and hand osteoarthritis to test symptom relief and longer-term joint outcomes
- Studies assessing whether existing therapies can improve pain control and preserve mobility
- Clinical work aimed at better understanding treatment effectiveness in everyday rheumatology care
This area reflects a strong interest in practical treatment strategies for common joint disorders, with a clear focus on improving daily life for people living with chronic musculoskeletal disease.
Immune System Diseases
The site also conducts research in immune system diseases, particularly rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and polymyalgia rheumatica. These trials are centered on finding better ways to control inflammation, reduce steroid use, and optimize long-term treatment.
- Studies in rheumatoid arthritis exploring treatment adjustment and disease control
- Research in psoriatic arthritis and axial spondyloarthritis focused on treatment reduction strategies
- Trials in polymyalgia rheumatica evaluating therapies that may improve remission and reduce dependence on corticosteroids
These investigations support more personalized care for inflammatory conditions, with the aim of maintaining disease control while limiting unnecessary medication exposure.
Bacterial Infections and Mycoses
Another important research area at the hospital/clinic is bacterial infection research, especially prosthetic joint infection. The trials in this field are examining whether newer antibiotic approaches can be as effective as traditional combination treatments after joint replacement infection.
- Clinical research on prosthetic joint infection to compare treatment approaches for infected implants
- Studies focused on improving antibiotic selection for better recovery and fewer complications
- Work aimed at strengthening infection management after orthopedic procedures
This line of research is important for helping patients recover safely after joint surgery and for improving the treatment of difficult-to-manage bacterial infections.
Analytical, Diagnostic and Therapeutic Techniques and Equipment
The clinical trial portfolio also includes research into therapeutic techniques and treatment optimization, with studies assessing how dosing strategies and targeted therapies can improve outcomes in rheumatologic diseases. These projects look at better ways to use established medicines more effectively.
- Trials evaluating treatment optimization in rheumatoid arthritis through dose adjustment strategies
- Research on targeted therapy use in polymyalgia rheumatica to improve disease control
- Studies testing whether treatment reduction can remain effective in stable inflammatory disease
This area highlights a practical approach to improving care by refining how therapies are used in real-world rheumatology practice.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 28 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Sint Maartenskliniek Stichting4active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Sint Maartenskliniek Stichting7trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sint Maartenskliniek Stichting
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Concentration-Guided Tocilizumab Dose Reduction Versus Standard Dosing in Rheumatoid Arthritis: A Randomized, International, Multicenter, Non-Inferiority Trial | Reade revalidatie & reumatologie centrum te Amsterdam | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 28 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rituximab | 2 | Unknown | 2023-02-01 | 2023-02-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
